These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21976)

  • 1. [Anesthetic management for schizophrenic patients on chronic phenothiazine therapy (author's transl)].
    Murakawa T; Matsuki A; Oyama T
    Masui; 1977 Oct; 26(10):1154-61. PubMed ID: 21976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anesthetic experience with 62 schizophrenic patients on chronic antipsychotic drugs].
    Matsuki A; Kimura K; Maeda A; Kami T; Wakayama S
    Masui; 1987 Nov; 36(11):1808-12. PubMed ID: 2895818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
    Tegeler J; Lehmann E; Stockschlaeder M
    Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
    [No Abstract]   [Full Text] [Related]  

  • 4. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 5. [A longitudinal study on the EEG abnormalities in schizophrenic patients treated with neuroleptics (author's transl)].
    Mohri Y; Uchida F; Fujieda T; Miyagishi T
    Hokkaido Igaku Zasshi; 1978 Jul; 53(4):313-9. PubMed ID: 32126
    [No Abstract]   [Full Text] [Related]  

  • 6. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment.
    Matsuki A; Oyama T; Izai S; Zsigmond EK
    Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242
    [No Abstract]   [Full Text] [Related]  

  • 7. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of pipothiazine palmitate, after intramuscular administration in schizophrenic patients].
    Blanc M; Girard M; Granier F; Escande M; Cotonat J
    Therapie; 1986; 41(1):27-30. PubMed ID: 2871636
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects.
    Wen F; Tan J
    Acta Pharmacol Sin; 2003 Oct; 24(10):1001-5. PubMed ID: 14531942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].
    Volkov VP
    Klin Med (Mosk); 2011; 89(4):27-30. PubMed ID: 21932558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroral premedication before anesthesia. A comparison between diazepam and dixyrazine].
    Thomsen A; Krarup N; Fjeldborg N
    Ugeskr Laeger; 1979 Oct; 141(40):2742-9. PubMed ID: 43619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with the neuroleptic 19.366 R.P. (pipothiazine)].
    Arrojo Lois M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):309-12. PubMed ID: 31067
    [No Abstract]   [Full Text] [Related]  

  • 15. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course of psychopathologic and extrapyramidal motor symptoms during long-term treatment of schizophrenic patients with psycholeptic drugs (author's transl)].
    Schilkrut R; Duran E; Haverbeck C; Katz I; Vidal P
    Arzneimittelforschung; 1978; 28(9):1494-5. PubMed ID: 38807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug management and therapy resistance. A cross-sectional study of schizophrenic patients in a large psychiatric hospital].
    Mohr F; Bender W; Hubmann W; Mäsel K; Pior R
    Psychiatr Prax; 1992 Jul; 19(4):108-13. PubMed ID: 1354878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anesthetic management of hyperparathyroidism--a case report (author's transl)].
    Sakai T; Ishii T; Nakajo N
    Masui; 1977 Sep; 26(9):1052-8. PubMed ID: 926298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.